Nanjing Hicin Pharmaceutical Co., Ltd. (SHE:300584)
China flag China · Delayed Price · Currency is CNY
29.88
-0.88 (-2.86%)
Sep 10, 2026, 2:39 PM CST

SHE:300584 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
726.62671.05504.36517.83526.47578.32
Revenue Growth
26.06%33.05%-2.60%-1.64%-8.97%-18.12%
Gross Profit
556.95546.86411.29416.56392.68468.39
Operating Income
10282.0652.445.9434.6329.41
Net Income
44.9742.0640.2236.3232.45285.88
Earnings Per Share
0.370.350.340.300.272.38
EPS Growth
0.73%4.60%10.74%11.91%-88.65%417.55%

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Northeast China Region
23.216.5519.9827.5856.56
North China
187.39108.4681.5673.4780.15
East China
256.82191.31220.46238.87249.78
Southern China
64.3548.7640.7730.9332.27
Central China Region
62.5947.846.9146.2453.96
Northwestern Region
29.8624.2924.5930.7431.63
Southwest Region
46.8467.1981.7174.9166.46
Total
671.05504.36517.83526.47578.32

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
22.8866.1945.7646.8295.07115.6
Total Debt
277.41286.73314.74271178.15180.28
Net Cash (Debt)
-254.52-220.54-268.98-224.18-83.09-64.68
Net Cash Growth
------
Net Cash Per Share
-2.12-1.84-2.24-1.87-0.69-0.54

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
11.5778.0959.9623.93-5.8259.94
Capital Expenditures
-40.64-62.64-77.94-197.22-218.94-94.41
Free Cash Flow
-29.0615.45-17.98-173.29-224.76-34.47
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
76.65%81.49%81.55%80.44%74.59%80.99%
Operating Margin
14.04%12.23%10.39%8.87%6.58%5.09%
Pretax Margin
7.43%7.05%8.14%7.28%5.47%57.14%
Profit Margin
6.19%6.27%7.97%7.01%6.16%49.43%
FCF Margin
-4.00%2.30%-3.56%-33.46%-42.69%-5.96%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.1000.1000.1000.050-0.250
Dividend Per Share Growth
0%0%100.00%--100.00%
Dividend Yield
0.32%0.20%0.50%0.22%-1.27%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
82.09143.2960.1576.93119.088.40
Forward PE
-26.2026.2026.2026.2026.20
P/FCF Ratio
-390.08----
PS Ratio
5.088.984.805.407.344.15